Dolutegravir, the current first-line treatment for HIV recommended by the World Health Organization (WHO) in 2019 is now showing less efficacy in people with NNRTI drug-resistant strains.
from Medindia Health News https://ift.tt/3mu9RwZ
No comments
Post a Comment
Thanks for comment via will connect you within 24 hours.